Leukocytoclastic vasculitis

被引:0
|
作者
Sunderkötter, C
Roth, J
Bonsmann, G
机构
[1] Univ Ulm Klinikum, Univ Klin & Poliklin Dermatol & Allergol, D-89081 Ulm, Germany
[2] Univ Klinikum Munster, Inst Expt Dermatol, Munster, Germany
[3] Univ Klinikum Munster, Univ Kinderklin, Munster, Germany
[4] Univ Klinikum Munster, Klin & Poliklin Hautkrankheiten, Munster, Germany
来源
HAUTARZT | 2004年 / 55卷 / 08期
关键词
leukocytoclastic vasculitis; purpura; immune complex; Henoch-Schonlein purpura; hypersensitivity vasculitis; ANCA;
D O I
10.1007/s00105-004-0760-1
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Leukocytoclastic vasculitis (LcV) is the most common form of cutaneous vasculitis. Often LcV results from deposition of immune complexes in the vascular wall. When IgA is the dominant immunoglobulin in these complexes, systemic involvement is likely (Henoch-Schonlein purpura), being more severe in adults. LcV in which immune complexes are composed of IgG or IgM are more often limited to the skin and may additionally show minor systemic involvement. in other forms of LcV additional pathophysiological factors play a role. LcV can also be a presenting or accompanying symptom of severe systemic ANCA-associated vasculitis. in some cases, LcV is a sign of bacteriemia. The aim of diagnostic procedures is to determine the specific type of vasculitis and degree of systemic involvement as well as possible causes. If no trigger or cause can be found, uncomplicated cases of LcV should be treated symptomatically. Corticosteroids are indicated at initial signs of necrosis or ulceration. Chronic recurrent LcV may respond to dapsone or colchicine. Severe systemic vasculitis requires immunosuppressive therapy.
引用
下载
收藏
页码:759 / 783
页数:25
相关论文
共 50 条
  • [42] Dengue fever and leukocytoclastic vasculitis
    Barraza, Monica
    Gomez, Ricardo
    Guillermo Santacruz, Juan
    UNIVERSITAS MEDICA, 2006, 47 (03): : 278 - 283
  • [43] Leukocytoclastic vasculitis due to duloxetine
    Erfan, Gamze
    Alp, Recep
    Albayrak, Sule
    Oguz, Keriman
    Kalayci, Serkan
    Oznur, Meltem
    Kulac, Mustafa
    EUROPEAN JOURNAL OF DERMATOLOGY, 2015, 25 (02) : 194 - 195
  • [44] Leukocytoclastic vasculitis and gastric adenocarcinoma
    Mebazaa, A.
    Chouk, S.
    Azzouz, H.
    El Euch, D.
    Cheikh Rouhou, R.
    Trojjet, S.
    Mokni, M.
    Zitouna, M.
    Ben Osman, A.
    ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA, 2010, 19 (01): : 21 - 23
  • [45] Leukocytoclastic vasculitis associated with clarithromycin
    Gavura, SR
    Nusinowitz, S
    ANNALS OF PHARMACOTHERAPY, 1998, 32 (05) : 543 - 545
  • [46] Leukocytoclastic vasculitis related to rofecoxib
    Palop-Larrea, V
    Melchor-Penella, MA
    Ortega-Monzó, C
    Martínez-Mir, I
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (11) : 1731 - 1732
  • [47] LEUKOCYTOCLASTIC VASCULITIS IN HEPATIC CIRRHOSIS
    PELEGRI, A
    CAMPOS, J
    PUJOL, M
    REGUAN, M
    MEDICINA CLINICA, 1985, 84 (20): : 842 - 843
  • [48] Leukocytoclastic vasculitis associated with rivaroxaban
    Sainz-Gaspar, Laura
    Pita da Veiga, Gabriela
    Suarez-Penaranda, Jose M.
    Vazquez-Veiga, Hugo
    Sanchez-Aguilar, Dolores
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2018, 57 (05) : 622 - 624
  • [49] Mechanisms of leukocytoclastic vasculitis (LcV).
    Sunderkotter, C
    Schonlau, F
    Schwarz, A
    Luger, T
    Sorg, C
    Kolde, G
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (04) : 332 - 332
  • [50] Leukocytoclastic vasculitis due to duloxetine
    Gamze Erfan
    Recep Alp
    Sule Albayrak
    Keriman Oguz
    Serkan Kalayci
    Meltem Oznur
    Mustafa Kulac
    European Journal of Dermatology, 2015, 25 : 194 - 195